{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:43:15Z","timestamp":1787942595690,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2002,10,1]]},"DOI":"10.1038\/sj.ijir.3900875","type":"journal-article","created":{"date-parts":[[2002,10,18]],"date-time":"2002-10-18T06:59:30Z","timestamp":1034924370000},"page":"406-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Pathophysiology of Peyronie's disease"],"prefix":"10.1038","volume":"14","author":[{"given":"R B","family":"Moreland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,10,18]]},"reference":[{"key":"BF3900875_CR1","first-page":"244","volume-title":"The penis.","author":"M Gelbard","year":"1993","unstructured":"Gelbard M . Peyronie's disease In: Hashmat AI Das S eds The penis. Lea and Febiger: Philadelphia 1993 pp 244\u2013365"},{"key":"BF3900875_CR2","first-page":"54","volume":"9","author":"S Carrier","year":"1994","unstructured":"Carrier S, Lue TF . For Peyronie's disease, act conservatively Contemporary Urol 1994 9: 54\u201365","journal-title":"Contemporary Urol"},{"key":"BF3900875_CR3","first-page":"75","volume-title":"Penile disorders Proceedings of the International Symposium on Penile Disorders, Hamburg, Germany, 26\u201327 January 1996.","author":"JP Pryor","year":"1997","unstructured":"Pryor JP . The management of Peyronie's disease In: Porst H, ed Penile disorders Proceedings of the International Symposium on Penile Disorders, Hamburg, Germany, 26\u201327 January 1996. Springer Verlag, Berlin 1997 pp 75\u201386"},{"key":"BF3900875_CR4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0094-1298(20)31417-6","volume":"15","author":"CJ Devine","year":"1988","unstructured":"Devine CJ, Horton CE . Peyronie's disease Clin Plast Surg 1988 15: 405\u2013409","journal-title":"Clin Plast Surg"},{"key":"BF3900875_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0022-5347(01)64222-8","volume":"158","author":"JP Jarow","year":"1997","unstructured":"Jarow JP, Lowe FC . Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction J Urol 1997 158: 1388\u20131390","journal-title":"J Urol"},{"key":"BF3900875_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","volume":"157","author":"CJ Devine","year":"1997","unstructured":"Devine CJ, Somers KD, Jordan GH, Schlossberg SM . Proposal: trauma as a cause of Peyronie's lesion J Urol 1997 157: 285\u2013290","journal-title":"J Urol"},{"key":"BF3900875_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0022-5347(17)53599-5","volume":"127","author":"JS Vande Berg","year":"1982","unstructured":"Vande Berg JS et al. Mechanisms of calcification in Peyronie's disease J Urol 1982 127: 52\u201354","journal-title":"J Urol"},{"key":"BF3900875_CR8","first-page":"147","volume":"179","author":"RJ Krane","year":"1997","unstructured":"Krane RJ . The treatment of loss of penile rigidity associated with Peyronie's disease Scand J Urol Nephrol Suppl 1997 179: 147\u2013150","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"BF3900875_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF01576355","volume":"8","author":"BL Gasior","year":"1990","unstructured":"Gasior BL et al. Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie's disease: a pharmacocavernosometric and pharmacocavernosographic study World J Urol 1990 8: 90\u201397","journal-title":"World J Urol"},{"key":"BF3900875_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0022-5347(17)35997-9","volume":"149","author":"JA Lopez","year":"1993","unstructured":"Lopez JA, Jarow JP . Penile vascular evaluation of men with Peyronie's disease J Urol 1993 149: 53\u201355","journal-title":"J Urol"},{"key":"BF3900875_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1359\/jbmr.1997.12.6.929","volume":"12","author":"KW Lyles","year":"1997","unstructured":"Lyles KW et al. Peyronie's disease is associated with Paget's disease of the bone J Bone Miner Res 1997 12: 929\u2013934","journal-title":"J Bone Miner Res"},{"key":"BF3900875_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0022-5347(17)52751-2","volume":"128","author":"LM Nyberg","year":"1982","unstructured":"Nyberg LM, Bias WB, Hochberg MC, Walsh PC . Identification of an inherited form of Peyronie's disease with an autosomal dominant inheritance and association with Dupuytren's contracture and histocompatability B7 cross-reactive antigens J Urol 1982 128: 48\u201352","journal-title":"J Urol"},{"key":"BF3900875_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0022-5347(01)65362-X","volume":"157","author":"DJ Ralph","year":"1997","unstructured":"Ralph DJ et al. The genetic and bacteriological aspects of Peyronie's disease J Urol 1997 157: 291\u2013294","journal-title":"J Urol"},{"key":"BF3900875_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0022-5347(01)65363-1","volume":"157","author":"MS Leffell","year":"1997","unstructured":"Leffell MS . Is there an immunogenetic basis for Peyronie's disease? J Urol 1997 157: 295\u2013297","journal-title":"J Urol"},{"key":"BF3900875_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0090-4295(97)00333-6","volume":"50","author":"D Schiavino","year":"1997","unstructured":"Schiavino D et al. Immunologic findings in Peyronie's disease: a controlled study Urology 1997 50: 764\u2013768","journal-title":"Urology"},{"key":"BF3900875_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0022-5347(17)32828-8","volume":"152","author":"S Stewart","year":"1994","unstructured":"Stewart S, Malto M, Sandberg L, Colburn KK . Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease J Urol 1994 152: 105\u2013106","journal-title":"J Urol"},{"key":"BF3900875_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0022-5347(01)65364-3","volume":"157","author":"RF Diegelmann","year":"1997","unstructured":"Diegelmann RF . Cellular and biochemical aspects of normal and abnormal wound healing: an overview J Urol 1997 157: 298\u2013302","journal-title":"J Urol"},{"key":"BF3900875_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0022-5347(17)37988-0","volume":"146","author":"MB Lindsay","year":"1991","unstructured":"Lindsay MB et al. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984 J Urol 1991 146: 1007\u20131009","journal-title":"J Urol"},{"key":"BF3900875_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ajcp\/52.3.361","volume":"52","author":"BH Smith","year":"1969","unstructured":"Smith BH . Subclinical Peyronie's disease Am J Clin Pathol 1969 52: 385\u2013390","journal-title":"Am J Clin Pathol"},{"key":"BF3900875_CR20","first-page":"117","volume":"4","author":"G-L Hsu","year":"1992","unstructured":"Hsu G-L et al. The three-dimensional structure of the tunica albuginea: anatomical and structural levels Int J Impot Res 1992 4: 117\u2013132","journal-title":"Int J Impot Res"},{"key":"BF3900875_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0022-5347(17)35214-X","volume":"151","author":"G-L Hsu","year":"1994","unstructured":"Hsu G-L et al. Anatomy and strength of the tunica albuginea: its relevance to penile prosthesis extrusion J Urol 1994 151: 1205\u20131208","journal-title":"J Urol"},{"key":"BF3900875_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0022-5347(01)65359-X","volume":"157","author":"G Brock","year":"1997","unstructured":"Brock G et al. The anatomy of the tunica albuginea in the normal penis and in Peyronie's disease J Urol 1997 157: 276\u2013281","journal-title":"J Urol"},{"key":"BF3900875_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0022-5347(01)65358-8","volume":"157","author":"CJ Devine","year":"1997","unstructured":"Devine CJ . International Conference on Peyronie's Disease: Introduction J Urol 1997 157: 272\u2013275","journal-title":"J Urol"},{"key":"BF3900875_CR24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/j.1939-4640.1996.tb01757.x","volume":"17","author":"V Gentile","year":"1996","unstructured":"Gentile V et al. Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive function J Androl 1996 17: 96\u2013103","journal-title":"J Androl"},{"key":"BF3900875_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0022-5347(17)40920-7","volume":"141","author":"KD Somers","year":"1989","unstructured":"Somers KD et al. Isolation and characterization of collagen in Peyronie's disease J Urol 1989 141: 629\u2013631","journal-title":"J Urol"},{"key":"BF3900875_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.ijir.3900310","volume":"10","author":"D Udelson","year":"1998","unstructured":"Udelson D et al. Engineering analysis of penile hemodynamic and structural dynamic relationships: Part I. Clinical implications of penile tissue mechanical properties Int J Impot Res 1998 10: 15\u201324","journal-title":"Int J Impot Res"},{"key":"BF3900875_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1464-410X.1997.26511.x","volume":"79","author":"E Akkus","year":"1997","unstructured":"Akkus E et al. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence Br J Urol 1997 79: 47\u201353","journal-title":"Br J Urol"},{"key":"BF3900875_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0022-5347(01)65366-7","volume":"157","author":"L van de Water","year":"1997","unstructured":"van de Water L . Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie's disease J Urol 1997 157: 306\u2013310","journal-title":"J Urol"},{"key":"BF3900875_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0022-5347(01)65367-9","volume":"157","author":"KD Somers","year":"1997","unstructured":"Somers KD, Dawson DM . Fibrin deposition in Peyronie's disease plaque J Urol 1997 157: 311\u2013315","journal-title":"J Urol"},{"key":"BF3900875_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI115821","volume":"90","author":"WA Border","year":"1992","unstructured":"Border WA, Ruoslahti E . Transforming growth factor-\u03b2 in disease: the dark side of tissue repair J Clin Inv 1992 90: 1\u20137","journal-title":"J Clin Inv"},{"key":"BF3900875_CR31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA . Transforming growth factor-\u03b2 in tissue fibrosis N Engl J Med 1994 331: 1286\u20131291","journal-title":"N Engl J Med"},{"key":"BF3900875_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/sj.ijir.3900328","volume":"10","author":"RB Moreland","year":"1998","unstructured":"Moreland RB . Is hypoxemia associated with penile fibrosis? Int J Impot Res 1998 10: 113\u2013120","journal-title":"Int J Impot Res"},{"key":"BF3900875_CR33","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI et al. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression J Urol 1997 158: 1391\u20131394","journal-title":"J Urol"},{"key":"BF3900875_CR34","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI et al. An animal model of Peyronie's-like condition associated with an increase in transforming growth factor-beta mRNA and protein expression J Urol 1997 158: 2284\u20132290","journal-title":"J Urol"},{"key":"BF3900875_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","volume":"81","author":"AI El-Sakka","year":"1998","unstructured":"El-Sakka AI et al. Histological and ultrastructural alterations in an animal model of Peyronie's disease Br J Urol 1998 81: 445\u2013452","journal-title":"Br J Urol"},{"key":"BF3900875_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0891-5849(96)00327-9","volume":"22","author":"G Poli","year":"1997","unstructured":"Poli G, Parola M . Oxidative damage and fibrogenesis Free Radical Biol. Med 1997 22: 287\u2013305","journal-title":"Free Radical Biol. Med"},{"key":"BF3900875_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1749-6632.1949.tb53914.x","volume":"52","author":"PL Scardino","year":"1949","unstructured":"Scardino PL, Scott WW . The use of tocopherols in the treatment of Peyronie's disease Ann NY Acad Sci 1949 52: 390\u2013394","journal-title":"Ann NY Acad Sci"},{"key":"BF3900875_CR38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0022-5347(17)66108-1","volume":"81","author":"CJD Zarafonetis","year":"1959","unstructured":"Zarafonetis CJD, Horran TM . Treatment of Peyronie's disease with potassium para-aminobenzoate (POTABA) J Urol 1959 81: 770\u2013772","journal-title":"J Urol"},{"key":"BF3900875_CR39","first-page":"250","volume":"4","author":"G Bartsch","year":"1981","unstructured":"Bartsch G, Menander-Huber KB, Huber W, Marberger H . Orgotein, a new drug for the treatment of Peyronie's disease Eur J Rheumatol Inflamm 1981 4: 250\u2013259","journal-title":"Eur J Rheumatol Inflamm"},{"key":"BF3900875_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000282228","volume":"47","author":"G Ludwig","year":"1991","unstructured":"Ludwig G . Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis) Urol Int 1991 47: 236\u2013239","journal-title":"Urol Int"},{"key":"BF3900875_CR41","first-page":"169","volume":"25","author":"G Primus","year":"1993","unstructured":"Primus G . Orgotein in the treatment of plastic induration of the penis (Peyronie's disease) Int Urol Nephrol 1993 25: 169\u2013172","journal-title":"Int Urol Nephrol"},{"key":"BF3900875_CR42","first-page":"189","volume":"34","author":"S Lenk","year":"1994","unstructured":"Lenk S, Schonberger B . Penile deviation-our therapeutic concept Acta Chir Hung 1994 34: 189\u2013194","journal-title":"Acta Chir Hung"},{"key":"BF3900875_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00421046","volume":"84","author":"L Flohe","year":"1988","unstructured":"Flohe L . Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes Mol Cell Biochem 1988 84: 123\u2013131","journal-title":"Mol Cell Biochem"},{"key":"BF3900875_CR44","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0022-5347(01)64224-1","volume":"158","author":"LA Levine","year":"1997","unstructured":"Levine LA . Treatment of Peyronie's disease with intralesional verapamil injection J Urol 1997 158: 1395\u20131399","journal-title":"J Urol"},{"key":"BF3900875_CR45","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","volume":"51","author":"J Rehman","year":"1998","unstructured":"Rehman J, Benet A, Melman A . Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single blind study Urology 1998 51: 620\u2013626","journal-title":"Urology"},{"key":"BF3900875_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","volume":"44","author":"E Akkus","year":"1994","unstructured":"Akkus E et al. Is colchicine effective in Peyronie's disease? A pilot study Urology 1994 44: 291\u2013295","journal-title":"Urology"},{"key":"BF3900875_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","volume":"149","author":"MK Gelbard","year":"1993","unstructured":"Gelbard MK, James K, Riach P, Dorey F . Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study J Urol 1993 149: 56\u201358","journal-title":"J Urol"},{"key":"BF3900875_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1464-410X.1997.02849.x","volume":"79","author":"JS Judge","year":"1997","unstructured":"Judge JS, Wisniewski ZS . Intralesional interferon in the treatment of Peyronie's disease: a pilot study Br J Urol 1997 79: 40\u201342","journal-title":"Br J Urol"},{"key":"BF3900875_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF02551115","volume":"29","author":"O Polat","year":"1997","unstructured":"Polat O et al. Peyronie's disease: intralesional treatment with interferon alpha 2-A and evaluation of results by magnetic resonance imaging Int Urol Nephrol 1997 29: 465\u2013471","journal-title":"Int Urol Nephrol"},{"key":"BF3900875_CR50","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1464-410X.1992.tb15836.x","volume":"70","author":"DJ Ralph","year":"1992","unstructured":"Ralph DJ, Brooks MD, Botazzo GF, Pryor JP . The treatment of Peyronie's disease with tamoxifen Br J Urol 1992 70: 648\u2013651","journal-title":"Br J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3900875.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3900875","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3900875.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T08:44:45Z","timestamp":1704617085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3900875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,1]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10,1]]}},"alternative-id":["BF3900875"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijir.3900875","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,1]]},"assertion":[{"value":"18 October 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}